Loomis, Sayles & Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7B | Buy |
|
|||||
|
2025
Q1 | $1.82B | Sell |
|
|||||
|
2024
Q4 | $1.52B | Buy |
|
|||||
|
2024
Q3 | $1.43B | Sell |
|
|||||
|
2024
Q2 | $1.47B | Buy |
|
|||||
|
2024
Q1 | $1.3B | Sell |
|
|||||
|
2023
Q4 | $1.28B | Sell |
|
|||||
|
2023
Q3 | $1.1B | Sell |
|
|||||
|
2023
Q2 | $1.15B | Sell |
|
|||||
|
2023
Q1 | $1.06B | Sell |
|
|||||
|
2022
Q4 | $1.09B | Sell |
|
|||||
|
2022
Q3 | $1.2B | Sell |
|
|||||
|
2022
Q2 | $1.26B | Sell |
|
|||||
|
2022
Q1 | $1.67B | Sell |
|
|||||
|
2021
Q4 | $1.46B | Sell |
|
|||||
|
2021
Q3 | $1.27B | Buy |
|
|||||
|
2021
Q2 | $414M | Buy |
|
|||||
|
2021
Q1 | $214K | Buy |
|
|||||
|
2020
Q4 | $44K | Sell |
|
|||||
|
2020
Q3 | $170K | Buy |
|
|||||
|
2020
Q2 | $136K | Sell |
|
|||||
|
2020
Q1 | $121K | Buy |
|
|||||
|
2019
Q4 | $106K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $288M | Sell |
|
|||||
|
2014
Q1 | $245M | Sell |
|
|||||
|
2013
Q4 | $279M | Hold |
|
|||||
|
2013
Q3 | $285M | Sell |
|
|||||
|
2013
Q2 | $318K | Buy |
|